Universe Pharmaceuticals INC
Sector: Pharmaceutical PreparationsIndustry: Drug Manufacturers - Specialty & GenericCountry: CNExchange: Nasdaq
DilutionScan read 32 of Universe Pharmaceuticals INC's SEC filings and found 3 warrant series, 2 shelf registrations and 1 completed offering on file for UPC. The latest dilution event on file is a registration statement on Oct 9, 2026. Analysis updated Oct 29, 2026.
Signal8 Summary
UPC
Shrinking revenue, burning cash, dilutive acquisition
Snapshot
Universe Pharmaceuticals is a tiny Chinese traditional medicine maker with a shrinking business and a strained balance sheet. Revenue fell 22.4% to $17.9 million in FY 2025, while the company lost $3.7 million in net income and burned $5.4 million in free cash flow. The company holds $33.6 million in cash against $9.3 million in debt, providing a 17.5-month runway at current burn rates.
What's Happening Right Now
- : Universe Pharmaceuticals agreed to acquire Best Praise International for $10.75 million in shares to expand its patent portfolio for age-related diseases.
- : The company adopted a new equity incentive plan and issued shares to CEO Gang Lai, consolidating his control over 75% of voting power.
